Highlights Sartorius Stedim Biotech

Equities

Market Closed - Euronext Paris Other stock markets 11:35:08 2024-04-26 am EDT			5-day change	1st Jan Change
208.3 ^EUR	+2.41%		+3.84%	-13.03%

Apr. 23	SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	ZD
Apr. 22	Sartorius Stedim: in the red with brokerage comments	CF

SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss	Apr. 22
SARTORIUS STEDIM : UBS reduces target price	Apr. 22	CF
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Sartorius and subsidiary Stedim under pressure after weak figures	Apr. 18	DP
Sartorius Stedim: Quarterly EPS more than halved	Apr. 18	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	Apr. 18	MT
Ex-dividend day for final dividend	Apr. 01	FA
Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost	Feb. 16	MT
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Stedim Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Sartorius Stedim: dividend set for 2023	Feb. 08	CF
Dpa-AFX Overview: COMPANIES from 07.02.2024 - 15:15	Feb. 07	DP
Debt reduction: Sartorius sells shares - Stedim with capital increase	Feb. 07	DP
Sartorius Stedim Biotech Shares Fall After Capital Increase	Feb. 07	DJ
Sartorius Stedim Biotech Completes $1.3 Billion Capital Increase	Feb. 07	DJ
Sartorius Stedim: private placement of 5.15 million shares	Feb. 07	CF
Sartorius Stedim Biotech Raises EUR1.2 Billion in Fresh Capital from Share Sale	Feb. 07	MT
Global markets live: LVMH, Intel, Tesla, Salesforce, Eli Lilly...	Jan. 26
Sartorius Stedim: annual net income divided by three	Jan. 26	CF

No results for this search

SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss

April 22, 2024 at 07:56 am EDT